SCHEMBL27099682

SCHEMBL27099682

C[Si](C)(P)c1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ESR1 P03372 1/20 0.44
▸ ESR2 Q92731 1/20 0.44
▸ NR1H2 P55055 2/20 0.35
▸ NR1H3 Q13133 2/20 0.35
▸ TSHR P16473 3/20 0.35
▸ ACHE P22303 2/20 0.35
▸ LMNA P02545 1/20 0.35
▸ ALOX12 P18054 1/20 0.35
▸ MAPT P10636 2/20 0.34
▸ NPC1 O15118 4/20 0.32
▸ RAB9A P51151 4/20 0.32
▸ SMN1; SMN2 Q16637 3/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ CES2 O00748 1/20 0.31
▸ CES1 P23141 1/20 0.31
▸ MEN1 O00255 1/20 0.31
▸ GAA P10253 1/20 0.31
▸ KMT2A Q03164 1/20 0.31
▸ TP53 P04637 1/20 0.30
▸ MAPK1 P28482 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28225522 0.81 ESR1 (0.44) ESR1ESR2NR1H2NR1H3TSHR
SCHEMBL10838037 0.75 ESR1 (0.44) ESR1ESR2NR1H2NR1H3TSHR
SCHEMBL5909371 0.75 ESR1 (0.44) ESR1ESR2NR1H2NR1H3TSHR
SCHEMBL28254856 0.73 TDP1 (0.39) ESR1ESR2TSHRACHELMNA
SCHEMBL63526 0.73 ESR1 (0.70) ESR1ESR2NR1H2NR1H3TSHR
SCHEMBL2169977 0.73 ESR1 (0.48) ESR1ESR2NR1H2NR1H3TSHR
SCHEMBL439492 0.73 ESR1 (0.48) ESR1ESR2NR1H2NR1H3TSHR
SCHEMBL239179 0.73 ESR1 (0.48) ESR1ESR2NR1H2NR1H3TSHR
SCHEMBL92396 0.73 ESR1 (0.48) ESR1ESR2NR1H2NR1H3TSHR
Cyanide SCHEMBL28194688 0.73 ESR1 (0.42) ESR1ESR2NR1H2NR1H3TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11912915-B2 Phosphine precursor for preparing quantum dot and quantum dot prepared therefrom SK CHEMICALS CO., LTD. (KR) 2024-02-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11912915-B2 Phosphine precursor for preparing quantum dot and quantum dot prepared therefrom WEE1, ORMDL3, WEE2 ESR1 4031/4885ESR2 3786/4885NR1H2 3367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback